FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 18 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
| Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
| Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
| SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
| FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
| TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
| Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
| AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
| Woodline Partners LP | 25,932 | $211,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |